ClinicalTrials.gg
Sign In

Gruppo Italiano Malattie EMatologiche dell'Adulto clinical trials

Listed in the registry as: University, hospital or other organization.

The registry lists 134 studies whose lead sponsor is Gruppo Italiano Malattie EMatologiche dell'Adulto. 35 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 9, 2026.

Keep track of what changes. Save the Gruppo Italiano Malattie EMatologiche dell'Adulto studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
57
Status unknown
22
Recruiting
20
Not yet recruiting
15
Active, not recruiting
11
Terminated
9

Phase

Phase 2
47
Phase 3
9
Phase 1
4
Phase 4
1

Where

Italy
117
Germany
6
Netherlands
4
Belgium
4
Austria
4
France
4

Focus areas

Conditions Gruppo Italiano Malattie EMatologiche dell'Adulto leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Leukemia66Precursor Cell Lymphoblastic Leukemia-Lymphoma24Leukemia, Lymphocytic, Chronic, B-Cell22Leukemia, Myelogenous, Chronic, BCR-ABL Positive21Leukemia, Myeloid, Acute20Purpura, Thrombocytopenic, Idiopathic10

Studies

Recruiting first, then most recently updated. Showing 50 of 134. Browse all 134 →